Janus Henderson Group
KPTI icon

Janus Henderson Group’s Karyopharm Therapeutics KPTI Stock Holding History

Janus Henderson Group’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,537
Closed -$68.3K – 2580
2023
Q2 		$68.3K Sell
2,537
-4
-0.2% -$172 ﹤0.01% 2581
2023
Q1 		$148K Buy
2,541
+1,728
+213% +$85.3K ﹤0.01% 2562
2022
Q4 		$41.5K Sell
813
-813
-50% -$56.4K ﹤0.01% 2428
2022
Q3 		$132K Buy
1,626
+811
+100% +$60.6K ﹤0.01% 2462
2022
Q2 		$55K Buy
815
+4
+0.5% +$367 ﹤0.01% 2546
2022
Q1 		$90K Hold
811
– – ﹤0.01% 2576
2021
Q4 		$78K Buy
+811
New +$80.8K ﹤0.01% 2519
2020
Q2 		– Sell
-216,855
Closed -$62.5M – 1353
2020
Q1 		$62.5M Buy
+216,855
New +$59.8M 0.04% 393

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return